No Fire Sale: Allergan May Sell Women’s Health, Infectious Disease Units
Executive Summary
Admitting these two areas are relatively small portions of Allergan overall, CEO Brent Saunders says it’s not yet time to consider a company split that would break off the Botox-centered aesthetic medicine portfolio as a separate business.